Experimental eye implant aims to halt vision loss in dry AMD

NCT ID NCT06557460

Recruiting now Disease control Sponsor: Regenerative Patch Technologies, LLC Source: ClinicalTrials.gov ↗

First seen Feb 04, 2026 · Last updated Apr 26, 2026 · Updated 9 times

Summary

This study tests an experimental implant (CPCB-RPE1) placed under the retina to treat advanced dry age-related macular degeneration with geographic atrophy. About 24 people aged 55-90 will take part, with most receiving the implant and a few receiving a sham procedure. The goal is to see if the implant can safely slow vision loss and improve retinal sensitivity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Retina Associates of Southern California
RECRUITING

Huntington Beach, California, 92647, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Retina Consultants of Texas
RECRUITING

The Woodlands, Texas, 77384, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Retina-Vitreous Associates Medical Group
RECRUITING

Beverly Hills, California, 90211, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
USC - Keck
RECRUITING

Los Angeles, California, 90033, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University Retina
RECRUITING

Lemont, Illinois, 60439, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.